Frostbite is a cold induced injury which occurs due to exposure of a particular site of body to sub-zero temperature. One of the primary reasons for lack of proper studies about the underlying mechanism of frostbite injury is due to non-availability of any reliable animal model and method for inflicting frostbite. In our current research, a device was designed and standardised to inflict frostbite wound in wistar rat. A formulation comprising different combination of essential oils was also developed and its activity was assessed and found effective in the treatment of frostbite wound.
Objectives: To explore the therapeutic role of a single dose combination of montelukast (MON) and dexamethasone (DXM) through intra-peritoneal route against paraquat (PQ)-intoxicated experimental Wistar rats. Methods: In vivo the survival rate was investigated following the administration of both MON and DXM in PQ exposed rats. Lungs parameters including enhanced pause (Penh), tidal volume (TV) and breath per minute (BPM) were determined using the whole body plethysmograph (WBP). Further chest imaging and histopathological studies were conducted to evaluate the lungs injury. In vivo the antioxidant activity was carried out by determining the levels of catalase (SOD), superoxide dismutase (CAT) and glutathione peroxidase (GSH-Px). Lungs tissue concentration of different proinflammatory cytokines like IL-1β, IL-6, TGF-β1 and TNF-α was also determined. Finally, expression of NF-kB and p-NF-kB was investigated by western blot. Results: Results of survival rate and levels of lungs parameters indicated therapeutic potential of combination treatment of MON and DXM. Protective activity on lungs was reflected in chest imaging and histopathological investigations. Moreover, combination treatment exhibited significant increased levels of all anti-oxidant parameters. Significant decrease in the levels of IL-1β; IL-6; TGF-β1 and TNF-α was also observed with the combination treatment of MON and DXM. Evidence of significant down regulation of NF-kB and phospho-NF-kB was also found with the combination treatment of MON and DXM. Conclusions: Given the advantage of therapeutic synergism activity of MON and DXM, it may be used in the prophylaxis of PQ-intoxication following clinical trials.
The healing of tissues is a highly coordinated development process which includes cell proliferation and differentiation, immune modulation, and extracellular‐matrix remodeling. Genetic variation, which encompasses single‐nucleotide polymorphisms (SNPs) and copy‐number variations (CNVs), and epigenetic corrections such as DNA methylation, post‐translational changes to histones, and non‐coding RNA activity might impact regenerative capacity and individual response to injury. High‐throughput sequencing and molecular profiling technologies have made it feasible to conduct genome and epigenome‐wide studies, clarifying how genomic and epigenomic contributions impact reparative processes. For example, certain SNPs may alter signaling pathways that induce tissue growth and, likewise, epigenetic changes may alter gene‐expression patterns following injury that may affect healing. Furthermore, combining genomic and epigenomic data will allow for the development of therapies specific to an individual's capacity for repair and susceptibility for scarring. While biomarker discovery, the identification of molecular features that correlate with the efficiency of healing and/or responsiveness to treatment, would additionally provide a tangible example of precision regenerative medicine. Regenerative strategies targeting a genetic mutation or secondarily changing the epigenome to promote tissue healing would provide an opportunity to improve healing outcomes by connecting molecular mechanisms to therapeutic interventions, which would enhance regeneration while also minimizing fibrosis and other unwanted effects.